The DNA methylation machinery as a target for anticancer therapy.
about
Histone modifications, DNA methylation, and schizophreniaMolecular characterization of Plasmodium falciparum S-adenosylmethionine synthetaseCharacterization of the human DNA methyltransferase splice variant Dnmt1bThe DNMT1 target recognition domain resides in the N terminus.DNA methylation and cancer.Cloning and analysis of a novel human putative DNA methyltransferase.2,4-Dihydroxy and O2 Protonated Tautomers of dThd and Thd Coexist in the Gas Phase: Methylation Alters Protonation Preferences versus dUrd and Urd.Inhibition of tumorigenesis by a cytosine-DNA, methyltransferase, antisense oligodeoxynucleotide.Emerging anticancer therapeutic targets and the cardiovascular system: is there cause for concern?Modified oligonucleotides as bona fide antagonists of proteins interacting with DNA. Hairpin antagonists of the human DNA methyltransferase.Multiple domains are involved in the targeting of the mouse DNA methyltransferase to the DNA replication foci.DNA methyl transferase 1: regulatory mechanisms and implications in health and disease.Concurrent replication and methylation at mammalian origins of replication.Gene silencing by S-adenosylmethionine in muscle differentiation.Genomic structure of the human DNA methyltransferase gene.Silencing of metallothionein-I gene in mouse lymphosarcoma cells by methylation.Feedback regulation of DNA methyltransferase gene expression by methylation.Evaluation of Tet-on system to avoid transgene down-regulation in ex vivo gene transfer to the CNS.DNA methyltransferase is a downstream effector of cellular transformation triggered by simian virus 40 large T antigen.Measurement of oxidized and methylated DNA bases by HPLC with electrochemical detection.Evidence of gender-and tissue-specific promoter methylation and the potential for ethinylestradiol-induced changes in Japanese medaka (Oryzias latipes) estrogen receptor and aromatase genes.Theoretical study of the pre- and post-translational effects of adenine and thymine tautomers and methyl derivatives.MG98, a second-generation DNMT1 inhibitor, in the treatment of advanced renal cell carcinoma.
P2860
Q24606593-38AB90B6-59D0-4795-9D33-0BA90553D4FEQ27973445-67D18EBF-494A-46AD-8F01-8D48D1B9EDE8Q28141132-50585525-E267-4DB9-823B-61EEE7D94E67Q31650618-783600FD-AB33-4A50-A13D-C01B166220C8Q33875819-093E9BF0-6AB4-4088-8F0D-313589C440E0Q34469056-D5DDFD6C-9E4F-4209-9E47-65D4FA2FFC40Q35871162-39D12FD0-1A32-40A4-9A2A-D0F51E682D02Q35960841-300D6875-34A3-4511-A668-69DA31FEBAC8Q37723147-5ECFA711-8857-47C0-92C6-2403CD993F7EQ38328254-FC3944E0-7BB7-465D-B22F-0939179444C9Q38339378-C62AFCF5-6CEE-47D5-83CD-453151365C40Q38561038-2D701AC7-9A0D-4AAF-91BE-E686D70E1DC1Q39574915-989E2FB5-1D2C-4AFA-90A5-F1E21CE3A36DQ40765792-01D2CAD6-C995-4F31-A55B-49290D0254EEQ40855229-2B9D7AD8-B350-4425-AEA3-75651F09B48DQ40912306-00A36F51-2202-45A6-BF95-DE280CC37676Q40935417-1C5818C0-E310-42F0-94B0-4B3150728231Q42525849-B2E32B2D-A211-4826-8DDE-6D42A7153A81Q42817479-F3EA0B24-444C-46F4-A2E3-4355A4C61EFDQ42983300-D1342CFD-BB53-4FFB-A237-AD6EC8F55387Q44688243-F7F6D545-4DE9-4AA8-A2E5-0BC57644A67EQ46558158-312B3205-CB5B-4D73-81AC-9CF5E320D92BQ53270513-939065E8-619A-4CB3-96B4-7842E5BFEBEE
P2860
The DNA methylation machinery as a target for anticancer therapy.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
The DNA methylation machinery as a target for anticancer therapy.
@en
type
label
The DNA methylation machinery as a target for anticancer therapy.
@en
prefLabel
The DNA methylation machinery as a target for anticancer therapy.
@en
P1476
The DNA methylation machinery as a target for anticancer therapy.
@en
P2093
P356
10.1016/0163-7258(96)00002-2
P577
1996-01-01T00:00:00Z